Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Derks

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancerMerel J M van Velzen, Marieke Pape, Willemieke P M Dijksterhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2014
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancerArjen H G Cleven, Sarah Derks, Muriel X G Draht, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancerTessa S Groen-van Schooten, Rosalia Franco Fernandez, Nicole C T van Grieken, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2023
Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysisMarieke Pape, Linde M Veen, Thom M Smit, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
Promoter methylation precedes chromosomal alterations in colorectal cancer developmentSarah Derks, Cindy Postma, Peter T M Moerkerk, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|June 17, 2020
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor typesTom van den Ende, Héctor G van den Boorn, Nadine M Hoonhout, et al.
Carcinogenesis|March 31, 2009
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21Sarah Derks, Linda J W Bosch, Hanneke E C Niessen, et al.
International Journal of Cancer|November 19, 2025
Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparisonBenthe H Doeve, Steven C Kuijper, Geert Silversmit, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 28, 2022
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancerMerel J M van Velzen, Aafke Creemers, Tom van den Ende, et al.
The Journal of Pathology|August 24, 2023
Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinomaTom van den Ende, Ymke van der Pol, Aafke Creemers, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancerMerel J M van Velzen, Marieke Pape, Willemieke P M Dijksterhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2014
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancerArjen H G Cleven, Sarah Derks, Muriel X G Draht, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancerTessa S Groen-van Schooten, Rosalia Franco Fernandez, Nicole C T van Grieken, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2023
Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysisMarieke Pape, Linde M Veen, Thom M Smit, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
Promoter methylation precedes chromosomal alterations in colorectal cancer developmentSarah Derks, Cindy Postma, Peter T M Moerkerk, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|June 17, 2020
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor typesTom van den Ende, Héctor G van den Boorn, Nadine M Hoonhout, et al.
Carcinogenesis|March 31, 2009
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21Sarah Derks, Linda J W Bosch, Hanneke E C Niessen, et al.
International Journal of Cancer|November 19, 2025
Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparisonBenthe H Doeve, Steven C Kuijper, Geert Silversmit, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 28, 2022
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancerMerel J M van Velzen, Aafke Creemers, Tom van den Ende, et al.
The Journal of Pathology|August 24, 2023
Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinomaTom van den Ende, Ymke van der Pol, Aafke Creemers, et al.
Pageof 7